By Keith L. Carson
Volume 14, Issue 3 (Fall 2015)
The licensure of biologics is really taking off as we all hoped it would in the ‘90s. There are a number of key factors including the advanced ability to produce adeno-associated virus (AAV) with baculovirus expression technology (BET), as well as the ability of BET to produce antigens that can successfully be used as vaccines. Then of course, there is the first licensed human gene therapy from uniQure, which is based on AAV-1 that was derived from BET…
Citation: Carson KL. From the Editor-in-Chief: Good News! The Licensure of Biologics is Really Taking Off. BioProcess J, 2015; 14(3): 3. https://doi.org/10.12665/J143.Carson
Posted online July 28, 2026